PolyPeptide Group AG (SWX:PPGN)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
26.65
+2.15 (8.78%)
Mar 12, 2026, 5:30 PM CET

PolyPeptide Group AG Ratios and Metrics

Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
8799375778344,525-
Market Cap Growth
16.15%62.30%-30.79%-81.57%--
Enterprise Value
9121,0026557994,381-
Last Close Price
26.6528.4017.5225.32136.52-
PE Ratio
---108.6692.36-
Forward PE
-147.50-26.8676.21-
PS Ratio
2.552.971.943.0015.47-
PB Ratio
2.842.801.632.0010.36-
P/TBV Ratio
2.972.921.702.0810.73-
P/FCF Ratio
28.94273.70----
P/OCF Ratio
6.7911.1717.00154.5776.11-
PEG Ratio
-2.532.536.252.92-
EV/Sales Ratio
2.653.172.202.8814.98-
EV/EBITDA Ratio
40.1058.41-24.4550.64-
EV/EBIT Ratio
---64.5262.70-
EV/FCF Ratio
30.01292.65----
Debt / Equity Ratio
0.340.290.330.080.070.29
Debt / EBITDA Ratio
4.574.61-0.870.340.86
Debt / FCF Ratio
3.4228.75---5.85
Net Debt / Equity Ratio
0.110.100.08-0.01-0.250.20
Net Debt / EBITDA Ratio
1.752.00-2.36-0.18-1.280.59
Net Debt / FCF Ratio
1.0610.04-1.770.086.433.91
Asset Turnover
0.510.470.510.480.580.66
Inventory Turnover
2.062.182.311.781.761.80
Quick Ratio
0.730.901.091.042.040.81
Current Ratio
1.621.691.852.623.191.77
Return on Equity (ROE)
-10.05%-5.30%-12.81%1.84%15.78%19.16%
Return on Assets (ROA)
-0.62%-0.52%-3.34%1.34%8.68%8.13%
Return on Invested Capital (ROIC)
-1.94%-1.48%-8.19%3.43%20.21%18.82%
Return on Capital Employed (ROCE)
-1.20%-1.10%-6.60%2.60%13.70%16.20%
Earnings Yield
-3.69%-1.96%-8.29%0.92%1.08%-
FCF Yield
3.46%0.36%-2.65%-8.25%-0.38%-
Dividend Yield
----0.22%-
Payout Ratio
---124.51%--
Buyback Yield / Dilution
-1.74%-0.10%0.11%-2.74%-7.08%-
Total Shareholder Return
-1.74%-0.10%0.11%-2.74%-6.86%-
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.